Martha E. Manning's most recent trade in Marinus Pharmaceuticals Inc was a trade of 3,621 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on Aug. 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Marinus Pharmaceuticals Inc | Martha E. Manning | SVP, GEN. COUNSEL & CORP. SEC. | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 05 Aug 2024 | 3,621 | 60,263 (0%) | 0% | 1.1 | 4,092 | Common Stock |
| Marinus Pharmaceuticals Inc | Martha E. Manning | SVP, GEN. COUNSEL & CORP. SEC. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 49,125 | 49,125 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Martha E. Manning | SVP, GEN. COUNSEL & CORP. SEC. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 10,918 | 63,884 (0%) | 0% | 0 | Common Stock | |
| Marinus Pharmaceuticals Inc | E. Martha Manning | SVP, GEN. COUNSEL & CORP. SEC. | Sale of securities on an exchange or to another person at price $ 9.57 per share. | 20 Feb 2024 | 1,894 | 52,966 (0%) | 0% | 9.6 | 18,126 | Common Stock |
| Marinus Pharmaceuticals Inc | Manning Martha E. | SVP, GEN. COUNSEL & CORP. SEC. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 98,250 | 98,250 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Martha E. Manning | SVP, GEN. COUNSEL & CORP. SEC. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 21,835 | 54,860 (0%) | 0% | 0 | Common Stock | |
| Marinus Pharmaceuticals Inc | Martha E. Manning | SVP, GEN. COUNSEL & CORP. SEC. | Sale of securities on an exchange or to another person at price $ 9.54 per share. | 07 Aug 2023 | 2,169 | 33,036 (0%) | 0% | 9.5 | 20,692 | Common Stock |
| Marinus Pharmaceuticals Inc | Martha E. Manning | SVP, GEN. COUNSEL & CORP. SEC. | Sale of securities on an exchange or to another person at price $ 8.91 per share. | 07 Aug 2023 | 11 | 33,025 (0%) | 0% | 8.9 | 98 | Common Stock |
| Marinus Pharmaceuticals Inc | Martha E. Manning | VP, GEN. COUNSEL & CORP. SEC. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 74,468 | 74,468 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Martha E. Manning | VP, GEN. COUNSEL & CORP. SEC. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 16,548 | 35,205 (0%) | 0% | 0 | Common Stock | |
| Marinus Pharmaceuticals Inc | Martha E. Manning | VP Gen Counsel and Corp Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 5,790 | 18,657 (0%) | 0% | 0 | Common Stock | |
| Marinus Pharmaceuticals Inc | Martha E. Manning | VP Gen Counsel and Corp Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 57,900 | 57,900 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Martha E. Manning | VP Gen Counsel and Corp Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 12,867 | 12,867 (0%) | 0% | 0 | Common Stock | |
| Marinus Pharmaceuticals Inc | Martha E. Manning | VP Gen Counsel and Corp Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 57,500 | 57,500 | - | - | Stock option (right to buy) |